CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER

LYON

Total Received

$26.3M

Total Awards

Last Updated

Feb 20, 2026

Yearly Funding Trend

$23.8M

$2.5M

Top 16 Awards to CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER

Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through February 20, 2026.

Download CSV

Top 16 Awards to CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER
Award	Awarding Agency	Program	Place	FY	Obligation
ASST_NON_R01CA033193_075 IARC MONOGRAPHS ON THE IDENTIFICATION OF CARCINOGENIC HAZARDS TO HUMANS - SINCE 1971, THE IARC MONOGRAPHS ON THE IDENTIFICATION OF CARCINOGENIC HAZARDS TO HUMANS HAS PROVIDED AN E…	Department of Health and Human Services National Institutes of Health	93.113 ENVIRONMENTAL HEALTH	—	2024	$4,878,214
ASST_NON_R01DE025712_075 THE ROLE OF GERMLINE AND SOMATIC DNA MUTATIONS IN ORAL AND OROPHARYNGEAL CANCERS - PROJECT SUMMARY/ABSTRACT MOST CANCERS OF THE HEAD AND NECK ARE SQUAMOUS CELL CARCINOMAS (HNSCC)…	Department of Health and Human Services National Institutes of Health	93.121 ORAL DISEASES AND DISORDERS RESEARCH	—	2024	$3,277,665
ASST_NON_UH3CA202721_075 DEVELOPMENT, FIELD TESTING AND EVALUATION OF THE EFFICACY OF A HAND-HELD, PORTABLE AND AFFORDABLE THERMO-COAGULATOR TO PREVENT CERVICAL CANCER IN LOW- AND MIDDLE-INCOME COUNTRIES…	Department of Health and Human Services National Institutes of Health	93.395 CANCER TREATMENT RESEARCH	—	2024	$3,170,234
ASST_NON_UH3CA202730_075 DEVELOPMENT AND CLINICAL VALIDATION OF A MULTI-TYPE HPV E6/E7 ONCOPROTEIN TEST FOR CERVICAL CANCER SCREENING AND TRIAGE IN LOW- AND MIDDLE-INCOME COUNTRIES - DESCRIPTION (PRO…	Department of Health and Human Services National Institutes of Health	93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH	—	2024	$2,831,005
ASST_NON_U01CA257679_075 INTERLYMPH CONSORTIUM: INTERROGATING PLEIOTROPY AND GENE BY ENVIRONMENT INTERACTIONS AMONG HEMATOPOIETIC MALIGNANCIES. - ABSTRACT MOST LYMPHOMAS AND MULTIPLE MYELOMA (MM) ARE MALI…	Department of Health and Human Services National Institutes of Health	93.393 CANCER CAUSE AND PREVENTION RESEARCH	—	2024	$2,685,053
ASST_NON_R01CA262164_075 THE LUNG EARLY PROTEINS PROJECT: A LEAP TOWARD IMPLEMENTING BIOMARKERS IN LUNG CANCER SCREENING - SUMMARY: THE LUNG EARLY PROTEINS (LEAP) PROJECT LUNG CANCER IS THE MOST COMMON CA…	Department of Health and Human Services National Institutes of Health	93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH	—	2024	$1,995,233
ASST_NON_R01CA244559_075 AFRICAN BREAST CANCER - DISPARITIES IN OUTCOMES - PLUS (ABC-DO PLUS) - PROJECT SUMMARY BREAST CANCER IS THE MOST COMMON TYPE OF CANCER DIAGNOSED AND THE SECOND CAUSE OF CANCER DE…	Department of Health and Human Services National Institutes of Health	93.393 CANCER CAUSE AND PREVENTION RESEARCH	—	2025	$1,929,057
ASST_NON_R37CA275824_075 A NOVEL, ONE STOP, AFFORDABLE, POINT OF CARE AND ARTIFICIAL INTELLIGENCE SUPPORTED SYSTEM OF SCREENING, TRIAGE AND TREATMENT SELECTION FOR CERVICAL CANCER AND PRECANCER IN THE LMI…	Department of Health and Human Services National Institutes of Health	93.393 CANCER CAUSE AND PREVENTION RESEARCH	—	2024	$1,730,892
ASST_NON_OT2CA278681_075 PROMINENT - IARC - THE CANCER RESEARCH COMMUNITY IS ON THE VERGE OF A MAJOR LEAP IN OUR UNDERSTANDING OF THE FACTORS THAT CONTRIBUTE TO HUMAN CANCER RISK. WHILE IT IS CLEAR THAT M…	Department of Health and Human Services National Institutes of Health	93.393 CANCER CAUSE AND PREVENTION RESEARCH	—	2024	$1,345,330
ASST_NON_U01CA289226_075 THE OPIOID COHORT CONSORTIUM (OPICO) TO INVESTIGATE THE EFFECTS OF USING OPIOIDS ON CANCER RISK - SUMMARY OVER THE PAST TWENTY YEARS, THE USE OF PRESCRIPTION OPIOIDS AMONG THE AME…	Department of Health and Human Services National Institutes of Health	93.393 CANCER CAUSE AND PREVENTION RESEARCH	—	2024	$1,157,721
ASST_NON_NU58DP007177_075 THE IARC HANDBOOKS OF CANCER PREVENTION - EVIDENCE-BASED EVALUATIONS OF PRIMARY AND SECONDARY CANCER PREVENTION APPROACHES - THE IARC HANDBOOKS OF CANCER PREVENTION PROVIDE AN EVI…	Department of Health and Human Services Centers for Disease Control and Prevention	93.135 CENTERS FOR RESEARCH AND DEMONSTRATION FOR HEALTH PROMOTION AND DISEASE PREVENTION	—	2024	$600,000
ASST_NON_R21CA256902_075 THE ROLE OF EPSTEIN BARR VIRUS AND HUMAN PAPILLOMA VIRUS CO-INFECTION IN CONJUNCTIVAL SQUAMOUS CELL CARCINOMA. - PROJECT SUMMARY CONJUNCTIVAL SQUAMOUS CELL CARCINOMA (SCC) IS A MA…	Department of Health and Human Services National Institutes of Health	93.396 CANCER BIOLOGY RESEARCH	—	2025	$288,712
ASST_NON_R03DE030257_075 GERMLINE RISK OF ORAL AND OROPHARYNGEAL CANCERS ACROSS DIVERSE POPULATIONS - PROJECT SUMMARY/ABSTRACT THERE IS STRIKING GEOGRAPHICAL VARIATION IN HEAD AND NECK CANCER SQUAMOUS CEL…	Department of Health and Human Services National Institutes of Health	93.121 ORAL DISEASES AND DISORDERS RESEARCH	—	2025	$221,817
ASST_NON_R03CA245979_075 EVALUATING RISK PREDICTION MODELS FOR USE IN LUNG CANCER SCREENING IN DIVERSE POPULATIONS AROUND THE WORLD - PROJECT SUMMARY SCREENING BY LOW-DOSE COMPUTED TOMOGRAPHY (CT) CAN RED…	Department of Health and Human Services National Institutes of Health	93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH	—	2024	$112,170
CONT_AWD_75F40121P00588_7524_-NONE-_-NONE- CONSORTIUM AGREEMENT - INTERNATIONAL COLLABORATION FOR CANCER CLASSIFICATION AND RESEARCH (IC3R)	Department of Health and Human Services Food and Drug Administration	—	SILVER SPRING, MD-08	2025	$33,638
CONT_AWD_75N91020P00652_7529_-NONE-_-NONE- TO DE-OBLIGATE FUNDS FROM FY2020 EXPIRING LINES FOLLOWING NIH OALM COMMUNICATION 25-06 (20241105).	Department of Health and Human Services National Institutes of Health	—	—	2025	$0

Top 16 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.